Navigation Links
BioCryst Receives Special Protocol Assessment for Fodosine

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the FDA's Special Protocol Assessment (SPA) process for the design of its planned pivotal clinical trial of the oral formulation of the company's lead oncology compound, Fodosine(TM) (forodesine hydrochloride) in patients with cutaneous T-cell lymphoma.

A Special Protocol Assessment is a request for feedback from the FDA that allows a company to receive official evaluation and guidance on the design of pivotal trial protocols. BioCryst requested the formal assessment, late in the first quarter of 2007, because the pivotal trial is intended to form the primary basis of an efficacy claim in the planned new drug application (NDA) for oral Fodosine.

The multicenter, multinational, open-label, single-arm, repeat-dose pivotal trial is expected to initiate enrollment during the third quarter of 2007. The trial will enroll patients with CTCL of Stage IB through Stage IVA who have disease that is persistent, progressive or recurrent during or after treatment with at least three systemic therapies. The study's primary endpoint is to determine the objective response rate, defined as either complete response or partial cutaneous response, achieved with a once-daily oral regimen of Fodosine(TM). Secondary endpoints include assessing the safety and tolerability of extended daily treatment with oral Fodosine(TM), assessment of the time to objective response and the duration of objective response.

"We are pleased to have reached agreement with the FDA in a timely manner. Receipt of this SPA is an important milestone in the development of Fodosine(TM) and a sign of our commitment to deliver on our goals," said Jon P. Stonehouse, Chief Executive Officer of BioCryst. "We would like to thank the FDA for their input and guidance during this SPA process. BioCryst is now well positioned to begin pati
'"/>




Page: 1 2

Related medicine news :

1. BioCryst’s Bird Flu Drug Enjoys Fast-Track Review By FD
2. Fifth US Patient Receives Artificial Heart
3. Northfield Labs Receives FDA Comments
4. British MPs Say Prostate Cancer Receives Low Priority in the NHS
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BioCryst Receives Special Protocol Assessment for Fodosine

(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 (HealthDay ... and produces an immune system response that could protect people ... reported by the U.S. National Institutes of Health. The ... paves the way for field-testing it in the Ebola-stricken West ... January, said Dr. Anthony Fauci, director of the NIH,s National ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Now that ... season has officially launched, Emassagechair.com has announced ... Monday Discount Event. , Negotiating on behalf of ... top massage chair brands, Emassagechair.com has generated significant buzz ... deals and biggest discounts yet. , Shoppers are excited ...
(Date:11/27/2014)... November 27, 2014 “LAB.C” was featured on ... the latest and coolest technology products available to consumers. Mallory ... product review and shared with viewers the company ... and Android devices. , Consumers love portability and functionality. ... Cable Case for the iPhone5 and 5S has a portable ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Aria ... Aria Health employees, prepared and donated 200 Thanksgiving ... Lutheran Settlement House , a non-profit, community-based organization ... living in Philadelphia. The dinners were assembled in ... Senior Center, and distributed to vulnerable low income ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web ... has announced online reputation management service. , ... comprehensive study about the world of internet marketing and ... Yahoo. , Ethane Web Technologies does not work ... first analyzes the project to reach a conclusion what ...
Breaking Medicine News(10 mins):Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2
... latest research shows that Viagra //(sildenafil) may also help ... breathe easier. Children diagnosed with pulmonary arterial hypertension ( ... high in the arteries that supply the lungs, leads ... if left untreated, could eventually lead to death of ...
... of vegetables in childhood lower risk// of stroke.This link ... a very interesting study published in the journal Heart. ... not just due to exposure to risk factors in ... an entire lifetime. Previous studies have suggested that diets ...
... The emergence of new disease like SARS, Ebola, Marburg and ... looked into from a global perspective. ,In an article ... US have suggested that instead of tackling these epidemics from ... should be tackled with a common health program for the ...
... thought of and may remain undetected because of this//, says ... of the spine is a disease that may affect young ... stiffness for a long time must be medically examined for ... relief from the condition for the children. Some symptoms of ...
... that is trying new approaches to the neuroblastoma patients, ... be more effective in children than the common procedure. ... feel that the cancer drug topotecancan must be fine ... not all doses are effective on everybody. Only less ...
... An interesting prospective study undertaken by the researchers at Massachusetts ... shown that higher intake of low-fat dairy may lower the ... II diabetes, either the body does not produce enough insulin ... the body to be able to use sugar. Type II ...
Cached Medicine News:Health News:Association between childhood diet and stroke 2
(Date:11/26/2014)... a leader in the development of Chimeric Antigen Receptors ... cancers, today announced the completion of a series A ... -based healthcare private equity fund.   CARsgen ... new therapeutics for liver, lung, stomach and brain cancers. ... Hospital, the company plans to initiate clinical studies for ...
(Date:11/26/2014)... DALLAS , November 25, 2014 ... Surgical Instruments Market by Power Source (Electric, Battery, ... Console, Cables, Blade, Burr, Cart), by Application (Orthopedic, ... 2019" published by MarketsandMarkets, the global Powered Surgical Instruments ... to $1.6 Billion in 2014 and is expected ...
(Date:11/26/2014)... NEW YORK , Nov. 25, 2014 /PRNewswire/ ... with Covidien has been widely discussed in ... but it,s also creating a stronger leading player ... according to Kalorama Information.  The healthcare market research ... monitoring systems will feature a diverse set of ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
Convenient clip-activated switch with removable cobalt blue filter attachment....
Portable video magnifier. This powerful new portable unit offers maximum flexibility and control. Includes a wider range of magnification settings, adjustable brightness, and even a tilted screen to ...
... the ideal video magnification solution for ... simple-to-use camera attached to a small ... on a mini xY reading table ... bag. Minimates versatility allows you to ...
... Flipperport brings flexibility and portability together ... main components: a high resolution color camera ... of lightweight glasses that display the magnified ... optimal portability, ease of use and comfort. ...
Medicine Products: